Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions
- PMID: 18270714
- PMCID: PMC2373858
- DOI: 10.1007/s00330-008-0870-8
Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions
Abstract
The value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in characterizing breast lesions on magnetic resonance imaging (MRI) was evaluated. Sixty-eight malignant and 34 benign lesions were included. In the scanning protocol, high temporal resolution imaging was combined with high spatial resolution imaging. The high temporal resolution images were recorded every 4.1 s during initial enhancement (fast dynamic analysis). The high spatial resolution images were recorded at a temporal resolution of 86 s (slow dynamic analysis). In the fast dynamic evaluation pharmacokinetic parameters (K(trans), V(e) and k(ep)) were evaluated. In the slow dynamic analysis, each lesion was scored according to the BI-RADS classification. Two readers evaluated all data prospectively. ROC and multivariate analysis were performed. The slow dynamic analysis resulted in an AUC of 0.85 and 0.83, respectively. The fast dynamic analysis resulted in an AUC of 0.83 in both readers. The combination of both the slow and fast dynamic analyses resulted in a significant improvement of diagnostic performance with an AUC of 0.93 and 0.90 (P = 0.02). The increased diagnostic performance found when combining both methods demonstrates the additional value of our method in further improving the diagnostic performance of breast MRI.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2373858/bin/330_2008_870_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2373858/bin/330_2008_870_Fig2_HTML.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2373858/bin/330_2008_870_Fig3_HTML.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2373858/bin/330_2008_870_Fig4_HTML.gif)
![Fig. 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2373858/bin/330_2008_870_Fig5_HTML.gif)
Similar articles
-
Kinetic Analysis of Benign and Malignant Breast Lesions With Ultrafast Dynamic Contrast-Enhanced MRI: Comparison With Standard Kinetic Assessment.AJR Am J Roentgenol. 2016 Nov;207(5):1159-1166. doi: 10.2214/AJR.15.15957. Epub 2016 Aug 17. AJR Am J Roentgenol. 2016. PMID: 27532897 Free PMC article.
-
Single bolus split dynamic MRI: Is the combination of high spatial and dual-echo high temporal resolution interleaved sequences useful in the differential diagnosis of breast masses?J Magn Reson Imaging. 2015 Jul;42(1):180-7. doi: 10.1002/jmri.24753. Epub 2014 Sep 11. J Magn Reson Imaging. 2015. PMID: 25211038
-
3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.AJR Am J Roentgenol. 2011 Dec;197(6):1498-505. doi: 10.2214/AJR.10.4665. AJR Am J Roentgenol. 2011. PMID: 22109308 Free PMC article.
-
[Quantitative parametric analysis of contrast-enhanced lesions in dynamic MR mammography].Radiologe. 2008 Jun;48(6):593-600. doi: 10.1007/s00117-007-1562-0. Radiologe. 2008. PMID: 18004537 Review. German.
-
Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging.Top Magn Reson Imaging. 1999 Apr;10(2):130-42. doi: 10.1097/00002142-199904000-00006. Top Magn Reson Imaging. 1999. PMID: 10551628 Review.
Cited by
-
High-Temporal/High-Spatial Resolution Breast Magnetic Resonance Imaging Improves Diagnostic Accuracy Compared With Standard Breast Magnetic Resonance Imaging in Patients With High Background Parenchymal Enhancement.J Clin Oncol. 2023 Oct 20;41(30):4747-4755. doi: 10.1200/JCO.22.00635. Epub 2023 Aug 10. J Clin Oncol. 2023. PMID: 37561962
-
Ktrans Calculation Using Reference Method Corrected Native T10 for Breast Cancer Diagnosis.J Med Phys. 2023 Jan-Mar;48(1):19-25. doi: 10.4103/jmp.jmp_90_22. Epub 2023 Apr 18. J Med Phys. 2023. PMID: 37342602 Free PMC article.
-
The Influence of Data-Driven Compressed Sensing Reconstruction on Quantitative Pharmacokinetic Analysis in Breast DCE MRI.Tomography. 2022 Jun 14;8(3):1552-1569. doi: 10.3390/tomography8030128. Tomography. 2022. PMID: 35736876 Free PMC article.
-
Improved value of whole-lesion histogram analysis on DCE parametric maps for diagnosing small breast cancer (≤ 1 cm).Eur Radiol. 2022 Mar;32(3):1634-1643. doi: 10.1007/s00330-021-08244-7. Epub 2021 Sep 9. Eur Radiol. 2022. PMID: 34505195
-
Use of Multiple-Tube Phantom: A Method to Globally Correct Native T1 Relaxation Time Inhomogeneity in Dedicated Molecular Magnetic Resonance Breast Coil.J Med Phys. 2021 Jan-Mar;46(1):41-46. doi: 10.4103/jmp.JMP_2_20. Epub 2021 May 5. J Med Phys. 2021. PMID: 34267488 Free PMC article.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15761078', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15761078/'}]}
- Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1023/B:BREA.0000032921.10481.dc', 'is_inner': False, 'url': 'https://doi.org/10.1023/b:brea.0000032921.10481.dc'}, {'type': 'PubMed', 'value': '15218359', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15218359/'}]}
- Boetes C, Veltman J, van Die L, Bult P, Wobbes T, Barentsz JO (2004) The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat 86:31–37 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMoa031759', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmoa031759'}, {'type': 'PubMed', 'value': '15282350', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15282350/'}]}
- Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM, Muller SH, Meijer S, Oosterwijk JC, Beex LV, Tollenaar RA, de Koning HJ, Rutgers EJ, Klijn JG (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427–437 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1148/radiol.2381042117', 'is_inner': False, 'url': 'https://doi.org/10.1148/radiol.2381042117'}, {'type': 'PubMed', 'value': '16373758', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16373758/'}]}
- Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S, Heywang-Kobrunner SH, Hylton N, Kuhl CK, Pisano ED, Causer P, Schnitt SJ, Thickman D, Stelling CB, Weatherall PT, Lehman C, Gatsonis CA (2006) Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 238:42–53 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/j.ejso.2006.06.009', 'is_inner': False, 'url': 'https://doi.org/10.1016/j.ejso.2006.06.009'}, {'type': 'PubMed', 'value': '16920327', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16920327/'}]}
- Van Goethem M, Tjalma W, Schelfout K, Verslegers I, Biltjes I, Parizel P (2006) Magnetic resonance imaging in breast cancer. Eur J Surg Oncol 32:901–910 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical